What is Avalo Therapeutics's earnings yield?

Avalo Therapeutics (AVTX) reported earnings yield of -24.9% in Q1 2026.

How has Avalo Therapeutics's earnings yield changed year-over-year?

Avalo Therapeutics's earnings yield decreased by 129.2% year-over-year, from 85.4% to -24.9%.

What is the long-term trend for Avalo Therapeutics's earnings yield?

Over 5 years (2020 to 2025), Avalo Therapeutics's earnings yield has grown at a -1.3% compound annual growth rate (CAGR), from -25.4% to -23.8%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Avalo Therapeutics AVTX Earnings yield

Earnings yield at other companies

Eli LillyLLY

3.1%+1.6pp

AbbVieABBV

0.9%-0.2pp

XencorXNCR

-19.5%-4.5pp

AnaptysBio, Inc.ANAB

-9.9%-2.8pp

AbCellera Biologics Inc.ABCL

-13.6%-4.3pp

Absci CorporationABSI

-25.8%-4.9pp

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$946.18M+1,783%

Enterprise value$921.19M-1,342%

P/S1,892.4×+1,852×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Calculated from Avalo Therapeutics’s reported figures.

net income/market cap=-24.9%

Based on trailing twelve months.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's earnings yield?: Avalo Therapeutics (AVTX) reported earnings yield of -24.9% in Q1 2026.
How has Avalo Therapeutics's earnings yield changed year-over-year?: Avalo Therapeutics's earnings yield decreased by 129.2% year-over-year, from 85.4% to -24.9%.
What is the long-term trend for Avalo Therapeutics's earnings yield?: Over 5 years (2020 to 2025), Avalo Therapeutics's earnings yield has grown at a -1.3% compound annual growth rate (CAGR), from -25.4% to -23.8%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.